Home / Hematology
Hematology
| 3 min read
New alliance will use Mission Bio’s Tapestri Platform to investigate Onconova’s rigosertib
| 10+ min read
Unveiling the true promise of stem cell therapy, not the empty promises
| 3 min read
Thermo Fisher Scientific, Eli Lilly ink agreement to develop companion diagnostic for identifying patients who could benefit from Lilly's RET inhibitor, which recently posted strong Phase 1/2 data
| 2 min read
ASTX727 has been granted orphan drug designation for the treatment of myelodysplastic syndromes by the FDA
| 3 min read
DiscGenics receives FDA Fast Track designation for cell therapy for disc degeneration
| 4 min read
Karyopharm announces the publication of Xpovio (selinexor) Phase 2b STORM study results in the New England Journal of Medicine
| 4 min read
Phase 2 study achieves primary endpoint, with topical endoxifen rapidly reducing breast density
| 3 min read
Catalyst Biosciences’ FVIIa variant meets all endpoints in Phase 2 trial
| 4 min read
Hesperos’ heart-liver Human-on-a-Chip correctly determines cardiotoxic mechanisms preclinically
| 10+ min read
The 2019 ASHG meeting will feature the latest research on human genetics
| 3 min read
FDA approves Bayer’s Nubeqa (darolutamide) for men with non-metastatic castration-resistant prostate cancer
| 3 min read
Some tumors can bypass the immune system by reactivating an embryonic gene
